# A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects

> **NCT01048203** · PHASE1 · COMPLETED · sponsor: **Active Biotech AB** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ABR-215050

## Key facts

- **NCT ID:** NCT01048203
- **Lead sponsor:** Active Biotech AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048203, "A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01048203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*